BioSpace News Archive

ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at the 9th Annual SVB Leerink Healthcare Conference on Wednesday, February 26, 2020

CAMBRIDGE, Mass., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report fourth quarter and full-year 2019 financial results after the Nasdaq Global Market closes on Wednesday, February 26, 2020. Subsequently, at 4:30 p.m. E.T., the Company will host a conference call to discuss its fourth quarter and full-year 2019 financial results and to provide a corporate update. The conference call may be acces

Feb. 19, 2020 13:35 UTC ORP-101 Currently in Phase 2 Study for Treatment of Irritable Bowel Syndrome with Diarrhea SAN FRANCISCO--( BUSINESS WIRE )-- OrphoMed, Inc., a clinical-stage biopharmaceutical company, today announced the presentation at Digestive Disease Week ® (DDW) of Phase 1 data for its lead candidate ORP-101, being developed for the treatment of irritable bowel syndrome with diarrhea. Anthony J. Lembo, M.D., Director of the GI Motility and Functional Bowe

SpendEdge has been monitoring the global amino acids market and the market is poised to experience spend growth of over USD 8 billion between 2018-2023 at a CAGR of more than 5% during the forecast period.

The Carolina-South Atlantic Chapter of the International Society for Pharmaceutical Engineering will host more than 1,300 life science and biotechnology professionals from major pharmaceutical companies, universities, and industries in the southeast and beyond at the 27th Annual ISPE-CaSA Life Sciences Technology Conference on Tuesday, March 10, 2020, from 9:30 a.m. though 4:15 p.m. at the Durham Convention Center in downtown Durham, N.C.

Today, Leo Lens Pharma (formerly DBA as Leo Lens Technology Co., Inc.) announced it received a notice of allowance from the USPTO for a patent for the use of its proprietary MediPrint™ process to manufacture a contact lens capable of providing enhanced myopia management.

Global health service company Cigna Corporation (NYSE: CI) announced today that Matt Manders, President, Strategy and Solutions, will present at the Barclays Global Healthcare Conference on March 11, 2020 in Miami, FL.

Infrared Cameras Incorporated, manufactures P and S Series IR Cameras, which provide accurate skin surface temperature readings from the first 1/1000th inch of epidermal layer; another product, IR Flash Software version 1.0, visualizes this data and allows for report building functionalities.

ChemomAb Ltd., a clinical-stage biotech company focusing on development of targeted innovative therapeutics for fibrosis-related diseases with great unmet need, announced that the Patent and Trademark Offices of the United States, Japan and China has granted composition of matter patent for CM-101, a first in class monoclonal antibody blocking CCL24,

Feb. 19, 2020 13:30 UTC Drug Candidate SK1‑I Shown to Markedly Decrease Lupus-Associated Immune Criteria and Kidney Inflammation in Preclinical Study Study is Further Confirmation of Enzo Biochem’s Proprietary Compound’s Potential for Treatment of this and other Autoimmune Diseases NEW YORK--( BUSINESS WIRE )-- Enzo Biochem, Inc. (NYSE:ENZ) today announced the publication of a study in The FASEB Journal by academic researchers that shows drug candidate “SK1‑I,” the c